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Background: The cyclic, disultlde-containing peptide, protein crystal lattice. The structure of the streptavidin- 
cycle-Ac-[Cys-His-Pro-Gin-Gly-Pro-Pro-Cys]-NHa, binds bound monomer, and that of the dimer that was eventu- 
to streptavidin with high affinity. In streptavidin-peptide aIIy produced from it in the crystal, were both 
cocrystals of space group 1222, cyclic peptide monomers determined from the same single crystal studied at differ- 
are bound on adjacent streptavidin tetramers related by a ent times. The two-fold symmetric peptide dimer was 
crystallographic two-fold symmetry axis. We set out to independently synthesized and shown to form crystals of 
determine whether the disulfide bonds of the peptide, pre- dimerized streptaviclin. 
sented close to one another in the crystal, could undergo Conclusions: We have shown that formation of a coval- 
disul6de interchange to form a dimer. ently linked peptide dimer can be mediated by a protein 
R.esults: When juxtaposed, the disulfides of neighboring crystal lattice. The dimer thus produced dimerizes its 
peptides undergo disulfide interchange, breaking and target, streptavidin, suggesting that solid-state (or 
fo~rming covalent disulfide bonds, to produce a peptide topochemical) reactions of this kind may be broadly useful 
dimer adopting the symmetry of the crystal. This is the for the preparation of Iigands that can dimerize other 
first example of a chemical transformation mediated by a protein targets. 
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Introduction 
Dimerization is a trigger for many important biological 
processes [l-4] including activation of intracellular 
kinases by membrane-bound cell surface receptors [l]. 
Dimerization is also important in transduction of 
signals from T-cell receptors [l], in the activity of tran- 
scription factors [S] and immunophilins [6,7], and in 
protein degradation [8]. Signaling via the human 
growth hormone receptor requires homodimerization 
of cytokine-binding domains to produce a 
cytokine-cytokine receptor complex with approximate 
C2 symmetry [9]. Monoclonal antibodies that dimerize 
this receptor are potent agonists [lo], indicating that 
proximity induced by dimerization suffices to elicit the 
intracellular response. Receptor homo- or heterodimer- 
ization is also induced by erythropoietin [ll], where 
the symmetry of the dimerized receptor may also be 
quasi-C2-symmetric (due to homology within the 
cytokine receptor class, reviewed in [1,2]). 
Since ligand-induced protein dimerization is such a 
ubiquitous signaling mechanism in biology, development 
of small molecules that dimerize target proteins may lead 
to compounds of pharmaceutical value. Streptavidin is a 
protein with a well characterized, high-resolution crystal 
structure.To gain insight into the structural and stereo- 
chemical criteria and constraints involved in designing 
ligands that promote protein dimerization, we have used 
streptavidin as a model system with which to study 
ligand-mediated dimerization of streptavidin tetramers. 
Screening of libraries of disulfide-linked cyclic pep- 
tides displayed on phage led to discovery of a 
high-affinity (Kd = 670 nM) cyclic, disulfide- 
crosslinked streptavidin ligand, cyclo-Ac-[Cys-His-Pro- 
Gln-Gly-Pro-Pro-Cys]-NH, [12].The structural basis 
for the affinity of this ligand was studied crystallo- 
graphically (B.A.K., unpublished data). Under some 
conditions this peptide undergoes disulfide inter- 
change in solution to produce a dimer with two inter- 
monomer disulfide bonds. In crystals of the 
streptavidin-peptide complex of space group 1222, 
cycle-Ac-[Cys-His-Pro-Gln-Gly-Pro-Pro-Cys]-NH, 
monomers are bound to adjacent streptavidin 
tetramers related by a crystallographic two-fold sym- 
metry axis. The disulfides of the peptide monomers 
are presented close enough to one another in the 
crystal to expect that a disulfide interchange reaction 
could occur within the crystal. 
When the pH of the streptavidin-peptide monomer 
I222 crystals was maintained at 5.0 or higher for several 
weeks, we observed interchange between the disulfides 
on adjacent, two-fold symmetry related strept- 
avidin-cyclo-Ac-[Cys-His-Pro-Gln-Gly-Pro-Pro- 
Cys]-NH, monomers to produce a C2-symmetric 
peptide dimer with two intermolecular disulfide bonds 
passing through one of the crystal’s two-fold symmetry 
axes (Fig. 1). We have thus established a strategy for pro- 
ducing a streptavidin-dimerizing ligand, by presentation 
of ligand monomers to each other within a protein 
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Fig. 1. Schematic diagram showing the disulfide interchange 
between peptide ligands and the resulting streptavidin-peptide 
dimerization occurring in 1222 crystals of the streptavidin-peptide 
monomer complex. The peptide segments before and after the 
amino-acid sequence His-Pro-Gin-Gly are schematic (some 
atoms are not shown). 
crystal lattice in an orientation that encourages a specific 
crosslinking reaction. A ligand dimer that can in turn 
dimerize the protein is thus produced. 
Here we describe the exploitation of packing interac- 
tions and symmetry in streptavidin crystals to mediate, 
within the crystal, a chemical reaction controlled 
‘topochemically’ by the appropriate presentation of 
reactive ligand groups. Topochemical reactions have 
been observed in small-molecule crystals. Stereospecific 
chemical reactions in chiral crystals have been used to 
provide a method of asymmetric synthesis [13]; such 
reactions include lattice-controlled photorearrange- 
ments [14-l 61, heterogeneous reactions [ 171 and 
thermal and photochemical reactions [18]. Other 
crystal-mediated, lattice-controlled reactions in small- 
molecule crystals include X-ray induced cycloaddition 
1191 or racemization [20], photochemical cycloaddition, 
dimerization and polymerization [14,21-241, and a 
thermal dimerization [25]. 
When crystal packing forces direct the reactions in 
small-molecule crystals, single crystal-to-single crystal 
chemical transformations can occur [19,23,26]. Such 
transformations involve conversion of reactants to prod- 
ucts within a crystal. We are aware of no other examples 
of such lattice-controlled transformations involving 
covalent chemistry within protein crystals, however. The 
protein crystal mediated transformation illustrated in 
Figure 1 is the first example of such a reaction. 
Results and discussion 
Two distinct structures determined in one crystal 
The structure, symmetry, and (2 1 F, I- ] F, I), OL, density 
for the two neighboring monomers in the 1222 crystal 
structure of streptavidin-cyclo-Ac-[Cys-His-Pro-Gln-Gly- 
Pro-Pro-Cys]-NH, monomer is shown in Figure 2a. 
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After six days of data collection on this crystal followed the crystal diffracted to better resolution than initially. 
by six weeks of incubation, the same crystal was re- Another complete data set was collected. Subsequent 
analyzed crystallographically. A large contraction in the refinement established that peptide monomers were 
cell volume (by 32 900 IL 5800 A3,Table 1) occurred, and crosslinked across a crystallographic two-fold axis. The 
Fig. 2 (cont.). (b) (21F,I-IF,/), a5 map 
for streptavidin-cyc/o-Ac-[Cys-Hrs-Pro- 
Gin-GHy-Pro-Pro-Cys]-NH2 dimer pro- 
duced by disulfide interchange in the 
crystal used for the structural determina- 
tion of the streptavidin-peptide 
monomer complex in (a) above, super- 
imposed on the refined structure. Both 
of the structures in (a) and (b) were 
determined using the same single 
crystal. (c) (2/F&-]F,I), CQ map for the 
streptavidin-bound cyc/o-Ac-[Cys-His- 
Pro-Cln-Gly-Pro-Pro-Cys]-NH, dimer 
ligand, chemically synthesized and then 
soaked into the crystals. An essentially 
identical structure was obtained when 
the dimer peptide was cocrystallized 
with streptavidin instead. 
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Table 1. Unit cell characteristics. 
na a (A) b 6) c (4 Volume (A3) 
Sulfate, pH 5.6 5 95.43 (29) 106.12 (11) 47.50 (22) 481 OOO(2700) 
Monomer, pH 5.0 5 97.65 (63) 107.61 (44) 49.46 (26) 519 700(4900) 
Dimer, same crystal 5 95.30 (30) 105.49 (28) 48.42 (24) 486800(3100) 
Dimer, cocrystal, pH 6.0 12 95.42 (41) 105.39 (23) 47.78 (22) 480500 (3200) 
Dimer, soaked, pH 6.0 18 95.60 (71) 106.84 (60) 48.45 (20) 494800(5000) 
Lattice parameters and cell volumes are for apostreptavidin (streptavidin sulfate), and streptavidin-cyc/o-Ac-[Cys-His-Pro-Gln-Gly- 
Pro-Pro-Cys]-NH1 monomer and dimer. 
an is the number of orientation matrices (determined from different batches of data) that were used to calculate averages and 
corresponding standard deviations (shown in parentheses). 
structure, symmetry and (2 ] F, I- 1 F, I), oc density of the 
streptavidin-bound peptide dimer produced after disulfide 
interchange in a crystal initially composed of the strept- 
avidin-peptide monomer complex are shown in Figure 
2b. One of the new crosslinks, the Cysl-Cysl’ disulfide 
(on the right of Fig. 2b) is unambiguously defined by 
density. The Cy&-Cys8’ disulfide is not as well defined by 
density, suggesting that it may be disordered. Mass 
spectrometry (see below) shows that the sulfurs are not 
modified; the molecular weight of the dimer is within 0.3 
mass units expected for the M+l species of a dimer with 
two disulfides. 
Synthetic peptide dimer dimerizes streptavidin 
To test the ability of a synthetic dimer to dimerize 
receptors, a ‘head-to-head’ cyclo-Ac-[Cys-His-Pro-Gln- 
Gly-Pro-Pro-Cys]-NH, peptide dimer was synthesized 
and cocrystallized with streptavidin.We determined and 
refined the structure of the streptavidin-peptide dimer 
cocrystal and also that of the same complex produced 
by soaking the pre-made head-to-head dimer into crys- 
tals. The structure of the protein-peptide dimer 
complex in these determinations is nearly identical to 
the structure resulting from dimerization of the 
monomer within the crystal. 
The structure of the chemically synthesized cyclo- 
Ac-[Cys-His-Pro-Gln-Gly-Pro-Pro-Cys]-NH, dimer 
soaked into a streptavidin crystal is shown in Figure 2c. 
The disulfide bond between Cysl and Cysl’ is again 
clearly defined. Density around Cys8 and Cys8’ remains 
weak or absent, again suggesting some disorder in this 
region of the peptide. 
In (1 F, I- ] F, I), (Y, maps of the streptavidin-bound 
peptide dimer where the sulfur atoms were omitted 
from the refinement and map calculations, and in 
(2 ) F, I- ( F, I), (Y, maps, the density for the disulfide 
involving the amino-terminal cysteines residues is well 
defined (Fig. 2~). The refined, unrestrained distance 
between the sulfur atoms of the amino-terminal cys- 
teine residues is 1.90 A, in close agreement with the 
accepted value of 2.02 A for a disulfide bond [27]. 
The refined, unrestrained dihedral angle about the S-S 
bond (x3) for this disulfide conformation is 86”, which 
is close to the optimal value for a right-handed disul- 
fide [28].The additional density connecting the amino- 
termini in Figure 2c shows that the amino-terminal 
disulfide also adopts a second, alternative conformation. 
Refined occupancies for both conformations give a 
ratio of 3:2. This is also the major conformation 
adopted by the single disulfide bond formed when a 
peptide that contains only one cysteine residue (either 
Phe-Cys-His-Pro-Gln-Asn-Thr-NH2 or Ac-Cys-His- 
Pro-Gln-Asn-Thr-NHJ, forms a homodimer in a 
cocrystal complex with streptavidin (B.A.K., R.T. Cass, 
B.L., N.C. & R.A., unpublished data). 
In both the streptavidin-bound monomer and dimer 
crystal structures, Pro7 and the two cysteines of the 
ligand are on the surface of the protein and do not 
interact with the protein. The density for these residues 
is not as well defined as that for the other ligand 
residues, which interact strongly with, and are as well 
defined as, the protein. Weak density and high tempera- 
ture factors for Pro7 and the two cysteines reflects the 
mobility and/or disorder of these residues. Table 2 
compares the temperature factors of some of the least 
mobile ligand atoms with those of the disulfide sulfurs 
in the streptavidin-bound peptide monomer and dimer 
crystal structures. 
Disulfide interchange induces crystal packing changes 
The lattice parameters and volumes for the strept- 
avidin-peptide monomer complex are significantly 
larger than those for the streptavidin-peptide dimer 
complex or for apostreptavidin (Table 1). The 
crystal structure of the streptavidin-peptide dimer 
complex produced by dimerization of the peptide 
monomer within the crystal, or by cocrystallization or 
soaking in the presence of chemically synthesized 
peptide dimer solution, show that the peptide 
monomers and the associated bound streptavidin 
tetramers are about 1.0 A closer together in 
the protein-peptide dimer complex than in the 
protein-peptide monomer complex. 
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Fig. 3. Schematic packing diagram for 
the streptavidin-peptide dimer crystal 
structure produced from disulfide inter- 
change within the crystal. The a-axis of 
the lattice is horizontal and the c-axis 
vertical. Dimerization occurs at the site 
l-site 1 binding sites. The site 2 
binding sites are separated by a larger 
distance and are not crosslinked. The 
two-fold axes in the a-c plane are rep- 
resented by arrows. The fractions of unit 
cell dimensions along the a and c 
directions are given. The peptides 
bound at site 2 that are obscured by the 
protein are represented by dotted lines. 
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Peptide dimers crosslink streptavidin tetramers HPLC and K-MS studies of disulfide interchange 
The packing diagram for the streptavidin-peptide dimer The crystal-induced dimerization of cyclo-Ac-[Cys-His- 
complex (Fig. 3) shows the two crystallographically inde- Pro-Gln-Gly-Pro-Pro-Cys]-NH, was confirmed by high 
pendent -streptavidin subunits, each with a bound performance liquid chromatography (HPLC) or by HPLC 
peptide. Binding site 1 on one subunit is close to a crys- coupled to mass spectrometry (LC-MS). Incubation of the 
tallographic two-fold axis, whereas site 2, on the crystal- monomer for nine days in the presence of crushed 1222 
lographically non-equivalent subunit, is not. Thus the streptavidin crystals results in two prominent peaks in 
streptavidin-cyclic peptide dimer complex has two sym- HPLC chromatograms (Fig. 4a). Electrospray and ion de- 
metry-related sites at which the peptide dimer crosslinks sorption mass spectrometry show that the first major peak 
the proteins, so that the crystals are composed of net- 
works of crosslinked streptavidin tetramers. The other 
is monomer (MWexperimental = 877.3 & 0.3 (15 measure- 
ments); MWcalculated (M+l) = 877.35), and that the 
binding site (site 2) is not involved in protein oligomer- second major peak is characteristic of a dimer with two 
ization in the crystal, and is more solvent-exposed.These 
relationships are shown schematically in Figure 3. 
disulfides (MW,,, = 1754.0; MWcalc, (M+l) = 1753.7). 
The fraction of dimer is -25 %. 
Table 2. Temperature factors for selected atoms. 
Gln4 0~1 Gln4 Ne2 His2 Ne2 His2 N61 Cysl s-y Cys8 Sy 
Monomer pH 5.0 7.5 15.1 12.1 12.1 68.3 69.8 
Dimer, same crystal, pH 5.0 12.3 14.1 17.2 15.8 67.8 80.2 
Dimer, cocrystal, pH 6.0 2.0a 4.9 28.7 27.7 55.0 90.6 
Dimer, soaked, pH 6.0 15.2 17.3 16.2 16.4 41.4b 88.0 
43.8 
Temperature factors are given in A2 for selected atoms in the cycle-Ac-[Cys-His-Pro-Cln-Cly-Pro-Pro-CysJ-NH, monomer and 
dimer ligands. 
aMinimum temperature factor allowed by Xplor [27]. 
bRefined occupancy in major conformation of 0.60 corresponds to B = 41.4 A2; refined occupancy in minor conformation of 
0.40 corresponds to B = 43.8 A*. 
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Fig. 4. HPLC chromatograms after incu- 
bation of cyc/o-Ac-[Cys-His-Pro-GIn- 
Giy-Pro-Pro-Cys]-NH2 monomer (1.5 x 
10m8 moles peptide at a concentration 
of 0.30 mM) for nine days in: (a) buffer 
containing finely crushed 1222 apo- 
streptavidin crystals from two sitting- 
drop crystallization setups. (The 
maximum possible amount of the crys- 
tals, based on the sitting-drop crystal- 
lization conditions, is 1 .O x 1 O-8 moles 
of subunits); (b) 50 % saturated ammo- 
nium sulfate, 50 % buffer, pH 7.0; (c) 
buffer containing a similar amount of 
non-crystalline streptavidin. (d) HPLC 
chromatogram resulting when the 
sample used for (a) was coinjected with 
chemically synthesized dimer, showing 
that the synthetic dimer comigrates with 
the dimer produced from the monomer 
in the crystals. (e) HPLC chromatogram 
of the supernatant from the sample used 
for (a). (f) HPLC chromatogram of crys- 
tals alone of sample (a) after thorough 
washing of the crystals. 
Although the disulfide involving the carboxy-terminal 
cysteines showed weak or absent density in the dimer 
structures (Fig. 2b,c), the mass obtained for the peptide 
dimer is within experimental error of that expected for a 
dimer with two disulfide crosslinks. Moreover, removal 
of a disulfide would require reduction of the peptide; 
since no reductants were present, and the solutions were 
accessible to oxygen from the air, it is highly unlikely 
that the second disulfide is not present. It is much more 
likely simply to be disordered in the crystal. 
The HPLC chromatogram of the monomer incubated at 
pH 7.0 in 50 % saturated ammonium sulfate for nine 
days in the absence of streptavidin (Fig. 4b) shows a pre- 
dominant monomer peak and very little dimer. In the 
negative control involving incubation of the monomer 
for nine days in the presence of non-crystalline strept- 
avidin (Fig. 4c) the minor dimer peak comprises only 
-5 % of the sample. These HPLC experiments demon- 
strate that disulfide interchange and peptide dimerization 
occur in the absence of X-ray irradiation. 
It is important to note that the peptide dimer that even- 
tually forms in the controls could be chemically different 
from that produced in the crystals, even though they 
comigrate on HPLC. (It is conceivable that the ‘head-to- 
tail’ dimer, or an inseparable mixture of the two possible 
dimers, might form in the controls described above.) 
This would only emphasize the important role of the 
crystal in directing the reaction, however. We did not 
investigate the identity of the disulfide bonds formed in 
solution in the absence of 1222 streptavidin crystals. 
Figure 5 shows the rate of crosslinked peptide dimer 
formation during incubation of the peptide monomer in 
the presence of streptavidin (in a cocrystallizing solution) 
(trace A), of 1222 streptavidin crystals (trace B), and of 
buffer alone (trace C). In the presence of 1222 streptavidin 
crystals, transition from monomer to dimer occurs within 
three days (Fig. 5, trace B). Under crystallization condi- 
tions in the presence of streptavidin (Fig. 5, trace A), the 
appearance of the dimer peak after 12 days coincided 
with crystallization. The larger fraction of dimer in trace 
A (-50 %) compared with trace B (-25 %) is attributed to 
a greater amount of streptavidin in the former sample. 
Protein crystal lattices can catalyze chemical reactions 
The chemical transformation induced in the crystal lattice 
of the streptavidin-cycZo-Ac-[Cys-His-Pro-Gln-Gly-Pro- 
Pro-Cys]-NH2 monomer complex has many features of 
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Fig. 5. Fraction of peptide dimer as a function of time deter- 
mined by integration of HPLC peaks for incubations of the 
monomer in the presence of streptavidin under conditions for 
producing 1222 crystals (trace A), 1222 streptavidin crystals 
(trace ES), or buffer alone (trace C). At the time point indicated by 
the arrow, streptavidin microcrystals were observed. 
reactions catalyzed by enzymesThe adjacent, bound cyclic 
peptide monomers are in productive orientations for the 
ensuing reaction, the effective concentration of the reac- 
tant is greatly raised, and binding involves H-bonds, 
ordered water molecules, and hydrophobic interactions at 
several sub-sites away from the receptor site. 
Unlike enzymatic catalysis, however, the crystal packing 
interactions in 1222 streptavidin crystals are unlikely to sig- 
nificantly stabilize the transition state for the disulfide inter- 
change reaction. In addition, the 1222 streptavidin crystals 
cannot catalyze more than one round of dimerization of the 
cyclic peptide monomer ‘substrate’ under these conditions 
(Fig. 5). The fraction of dimer after nine days (curve B in 
Fig. 5) presumably reflects conversion of all monomer mol- 
ecules initially bound at site 1, which are the limiting 
reagent of the reaction. No further increase in dimer con- 
centration is observed after 39 days, and more than half of 
the monomer remains throughout the time course. 
The successful preparation of the streptavidin-peptide 
dimer by soaking streptavidin crystals in dimer solution 
demonstrates that diffusion of the dimer into (and out 
of) the crystal lattice is possible, and thus product release, 
allowing catalytic turnover, is theoretically feasible. The 
expected affmity of the peptide dimer for the two adja- 
cent two-fold related binding sites in the crystals is high, 
however (-4.5 x lo-l3 M, on the order of the square of 
that for the monomer for a single site, 6.7 x lop7 M 
[12]). Thus the protein crystals are poorly optimized for 
product release and catalytic turnover. 
The high affinity of the peptide dimer for the 1222 crys- 
tals is demonstrated by the HPLC of the non-crystalline 
supernatant of the peptide monomer solution incubated 
with crystals, which shows predominantly monomer 
(Fig. 4e). The amount of monomer is similar to that 
found when the peptide is incubated for the same 
amount of time in buffer alone (Fig. 4~). The dimer 
is localized to the crystalline phase (Fig. 4f). Of the 
peptide bound in the crystal, 50 % is present as dimer at 
site 1 and 50 % as monomer at site 2 (Fig. 4f), where 
dimerization does not occur. 
Elucidation of the crystal structures of the strept- 
avidin-peptide monomer and dimer complexes has 
enabled us to design other peptides that are dimerizable 
by 1222 streptavidin crystals. Furthermore, these crystals 
are capable of catalyzing disulfide formation between 
ligands with a lower affinity for streptavidin than 
cycle-AC-[Cys-His-Pro-Gln-Gly-Pro-Pro-Cys]-NH2. 
The affinity of the linear peptide, Phe-Ser-His-Pro- 
Gln-Asn-Thr, (Kd =125 PM) [29] is about 200-fold 
lower than that of cyclo-Ac-[Cys-His-Pro-Gln-Gly- 
Pro-Pro-Cys]-NH2. Thus we reasoned that disulfide 
formation between linear cysteine-containing peptide 
analogs of Phe-Ser-His-Pro-Gln-Asn-Thr, such as Phe- 
Cys-His-Pro-Gln-Asn-Thr or Cys-His-Pro-Gln-Asn- 
Thr, might be catalyzed by the 1222 streptavidin crystal 
lattice, since the sulfhydryls of these peptide monomers 
that are bound at site 1, related by a nearby two-fold 
axis of symmetry, would be in close proximity. The K,s 
of these dimerized linear peptides for the two adjacent 
two-fold related binding sites in the crystals is expected 
to be -0.01 JJ,M (of the order of the square of the K, 
for the monomers), or higher. This affinity is of similar 
magnitude to the micromolar affinity of avidin for 
esters of the azo dye HABA (4’-hydroxyazobenzene-2- 
carboxylic acid); avidin is known to catalyze hydrolysis 
reactions of these esters in solution [30]. We have 
demonstrated catalysis by 1222 streptavidin crystals of 
disulfide formation between Phe-Cys-His-Pro-Gln- 
Asn-Thr monomers and determined the structure of 
the streptavidin-peptide dimer complex (B.A.K., R.T. 
Cass, B.L., N. C., & R. A., unpublished data). 
Significance 
We have described a novel crystal lattice medi- 
ated transformation within a single crystal of a 
protein. The dimerization of the streptavidin- 
bound cyclo-Ac-[Cys-His-Pro-Gln-Gly-Pro-Pro- 
Cys]-NH, monomer ligands, involving breaking 
and forming of covalent disulfide bonds, is to 
our knowledge the first example of a chemical 
reaction directed by a protein crystal lattice. 
Agents that cause the dimerization of proteins 
might be useful in a number of biological 
systems, but biological activity often requires 
dimerization in a precise orientation. The 
crystal lattice mediated dimerization of the 
peptide ligand in our model system suggests 
a general method for preparing ligands that 
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dimerize protein targets. First, a ligand for a 
monomeric protein is developed (e.g. by struc- 
ture-based design or screening). Two pieces of 
information are then required: the three-dimen- 
sional structure of the protein-ligand complex, 
and the relationship between the protein 
monomers in the desired protein dimer 
complex. With this information, one can intro- 
duce crosslinkable groups at sites in the ligand 
that do not interfere with ligand binding, and 
where a suitable crosslink could span the dis- 
tance between the two protein monomers 
in the biologically active dimer. Subsequent 
crosslinking of the introduced groups, by 
whatever method, produces a double-headed 
molecule that should be able to dimerize the 
protein target. 
In some cases, topochemistry of the kind 
described here may provide a powerful method 
of achieving the final step in this strategy. In the 
streptavidin model system, we relied on the fact 
that the ligand molecules are brought close to 
each other by crystal-packing interactions. In 
many cases, however, the biologically relevant 
dimer can be made to form in the absence of 
ligand by protein-protein interaction (for 
example, by increasing the protein concentra- 
tion). In such cases, the dimer could bind, orient 
and present the bound ligands toward one 
another in solution. 
The streptavidin model system provides an 
opportunity for developing strategies to dimer- 
ize this protein using peptides, peptidomimetics 
or small molecules produced by topochemistry 
and/or structure-based design. Ligands designed 
to dimerize other protein targets could be 
useful as leads for development of drugs tar- 
geted towards proteins whose biological activity 
involves dimerization. 
Materials and methods 
Peptide synthesis 
The synthesis of cyclo-Ac-[Cys-His-Pro-Gln-Gly-Pro-Pro- 
Cys]-NH, will be described elsewhere (B.A.K., unpublished 
data). Synthesis of the disulfide-bonded ‘head-to-head’, cyclo- 
Ac-[Cys-His-Pro-Gln-Gly-Pro-Pro-Cys]-NH, used ortho- 
gonal cysteine-protecting groups; the amino-terminal Cys 
was protected with trityl, the carboxy-terminal Cys with 
acetamidomethyl. The disulfide between the amino-terminal 
cysteines was formed by incubation in aqueous 0.010 M 
K3Fe(CN)6 at pH 8.5 for 1 h at room temperature. The 
second carboxy-terminal disulfide was formed by 
oxidation of the acetamidomethyl-protected cysteine 
residues with I, as described [31]. Cyclization was monitored 
by HPLC, and the peptide was purified by HPLC. 
HPLC/MS analysis was performed on a Finnigan MAT 
Single Stage Quadrapole (SSQ710) electrospray mass 
spectrometer. Mass found (M+l) = 1754; calculated 
(M+l) = 1754.Amino-acid analysis: Cys (3.8), His (2.1), Pro 
(5.7), Glx (2.0), Gly (2.0). 
X-ray crystallography 
Crystals of streptavidin-cy&Ac-[Cys-His-Pro-Gln-Gly-Pro- 
Pro-Cys]-NH, monomer were prepared by soaking large 
apostreptavidin [32] crystals in synthetic mother liquor at a 
peptide concentration of 10.0 mM, pH 5.0 for two days. A 
crystal of streptavidin-cyclo-Ac-[Cys-His-Pro-Gln-Gly-Pro- 
Pro-Cys]-NH2 dimer was produced by allowing the mounted 
crystal of streptavidin-bound monomer, from which data had 
been collected, to undergo disulfide interchange over a period 
of six weeks. Other crystals of the streptavidin-bound dimer 
were prepared by soaking large apostreptavidin crystals in syn- 
thetic mother liquor containing 5.0 mM chemically synthe- 
sized ‘head-to-head’ dimer. Finally, the streptavidin-dimer 
complex was cocrystallized using chemically synthesized 
dimer.These cocrystals were small and thin. 
Crystallographic data collection, data reduction, solution and 
refinement of structures were carried out by procedures that 
will be described elsewhere (B.A.K., unpublished). X-ray dif- 
fraction data from single crystals of streptavidin-bound cyc2o- 
Ac-[Cys-His-Pro-Gin-Gly-Pro-Pro-Cys]-NH, monomer or 
cycle-Ac-[Cys-His-Pro-Gln-Gly-Pro-Pro-Cys]-NH, dimer 
were collected on a Siemens IPC area detector coupled to a 
Siemens three-circle goniometer mounted on a Rigaku rotat- 
ing anode target tube operating at 50 kV, 60 mA.The size of 
the small cocrystal (0.18 x 0.12 x 0.01-0.03 mm) of strept- 
avidin-cyclo-Ac-[Cys-His-Pro-Gln-Gly-Pro-Pro-Cys]-NH, 
dimer allowed collection of data with reasonable statistics only 
to 2.65 A. 
A model of streptavidin with no inhibitor or waters near the 
expected binding regions of the peptide was built with 
Quanta (Molecular Simulations, 16 New England Executive 
Park, Burlington, MA 01803) from the structure of strepta- 
vidin-cyclo-Ac-[Cys-His-Pro-Gln-Gly-Pro-Pro-Cys]-NH~ 
monomer (B.A.K., unpublished). Initial electron density 
maps calculated with coefficients (lF,l-lF,l) or 
(2 ] F, I- I F, I ) and phases (cx,) for the model enabled deter- 
mination of the structure of the streptavidin-bound cyclic 
peptide dimer. 
Structures were refined with Xplor [27] and with difference 
Fourier methods [33]. Water structure was determined and 
refined as described [34]. Data collection and refinement statis- 
tics are given in Table 3. The structures will be deposited into 
the Brookhaven Data Bank. 
HPLC and LC-MS measurements 
A Hewlett-Packard 1090 analytical HPLC (Cl8 reverse-phase 
column) instrument was used. The linear gradient was from 
0.05 % trifluoroacetic acid in water to 0.05 % in acetonitrile 
over 15 minThe fraction of dimer in each sample was calcu- 
lated by dividing the integrated area of the dimer peak by the 
sum of the integrated areas of the monomer and dimer peaks. 
(Since the extinction coefficient of the dimer is expected to 
be twice that of the monomer (on a molar basis) the fraction 
of dimer thus calculated is on a weight basis). HPLC 
(Michrom BioResources Ultrafast Microprotein Analyzer) 
coupled to electrospray ionization mass spectrometry 
(Finnigan MAT SSQ710), or plasma desorption time-of-flight 
mass spectrometry (BioIon 20 instrument) was also done for 
selected samples. 
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Table 3. Crystallography parameters.a 
Parameters 
Number of atoms (including disorder) 2075 2151 2151 2111 
Number of water molecules (including disorder) 150 194 194 144 
Number of discretely disordered groupsb 0 3 3 4 
Number of discretely disordered waters 0 2 2 2 
Number of side chains with refined occsc 24 24 24 26 
Diffraction statistics 
Resolution (A) 
Number of observationsd 
Number of unique observations 
Redundancy 
R merge (oL4e 
Refinement statistics 
Refinement resolution 
Number of merged reflections 
I F,l/u cutoff 
R (%)f 
F;:!?Rcryst (%)g 
Overall completeness (%) 
Overall completeness at highest resolution (%) 
Highest resolution shell 
RMS deviationsh 
Bond lengths (A) 
Bond angles (“) 
Torsion angles (“) 
50-1.90 50-1.90 50-2.41 50-1.85 
64474 70104 15363 76657 
16042 17597 5622 20986 
4.0 4.0 2.7 3.7 
7.5 6.3 11.6 9.6 
7.5-2.00 7.5-1.95 9.5-2.65 7.5-2.00 
14 948 16025 4993 13 736 
1 .o 1.5 1.0 2.0 
19.1 17.2 14.3 19.7 
23.3 21.9 22.2 22.4 
84.7 89.8 69.4 79.5 
54.4 77.8 33.9 51.5 
2.09-2.00 2.04-1.95 2.77-2.65 2.09-2.00 
0.018 0.017 0.016 0.018 
3.2 3.2 3.5 3.4 
27.9 28.1 28.2 27.6 
Monomer Dimer Dimer Dimer 
crystal 1 crystal 1 (co-crystal) (soaked) 
pH 5.0 pH 5.0 pH 6.0 pH 6.0 
Crystallography statistics for streptavidin-bound cycle-Ac-[Cys-His-Pro-GJn-Cly-Pro-Pro-Cys]-NH2 monomer and dimer. 
aRestrained, isotropic temperature factors were refined for all structures. Bulk solvent contributions were included for all structures. 
bNot including waters. 
CAl~o includes ligand groups. Density for all side-chain atoms or for terminal atoms in these groups was weak or absent and tem- 
perature factors were high. Discretely disordered groups are not included in this category. Occupancies for poorly defined groups 
of atoms were refined. 
dData with Rsym > 50 % were rejected along with data with values > 3.5 (r from the mean for several symmetry equivalents. 
eR 
f$=;F 
= &,&jl(h)i - <I(h)>j/ChCil(h)i, where J(h)i is Jhe ith observation of the intensity of reflection h. 
C(IIF,I-IF,jI)/cIF,I (for reflections from 7.5 A to the highest resolution). 
gCross validation R-factor using 10 % of the data withheld from the refinement [35]. The structure was first determined and refined. 
Subsequently IO % of the data was withheld and the structure re-refined to convergence. 
hRoot-mean-square deviations from ideal bond lengths and bond angles. 
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